Cited by 381Cytokine Signaling Pathways and InteractionsInflammatory Bowel DiseasePsoriasis: Treatment and Pathogenesis

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

STAT3 deletion during hematopoiesis causes Crohn’s disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity

Open access

Welte, Thomas, Zhang, Samuel S. M., Wang, Tian, Zhang, Zhiyuan, Hesslein, David G. T., Yin, Zhinan, Kano, Arihiro, Iwamoto, Yoshiki, Li, En, Craft, Joseph E., Bothwell, Alfred L. M., Fikrig, Erol, Koni, Pandelakis A., Flavell, Richard A., Fu, Xin-Yuan·2003·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0237137100PMC PMC149927

Open this paper in CoChat — free account

Abstract

Signal transducer and activator of transcription 3 (STAT3) is a key transcriptional mediator for many cytokines and is essential for normal embryonic development. We have generated a unique strain of mice with tissue-specific disruption of STAT3 in bone marrow cells during hematopoiesis. This specific STAT3 deletion causes death of these mice within 4-6 weeks after birth with Crohn's disease-like pathogenesis in both the small and large intestine, including segmental inflammatory cell infiltration, ulceration, bowel wall thickening, and granuloma formation. Deletion of STAT3 causes significantly increased cell autonomous proliferation of cells of the myeloid lineage, both in vivo and in vitro. Most importantly, Stat3 deletion during hematopoiesis causes overly pseudoactivated innate immune responses. Although inflammatory cytokines, including tumor necrosis factor alpha and IFN-gamma, are overly produced in these mice, the NAPDH oxidase activity, which is involved in antimicrobial and innate immune responses, is inhibited. The signaling responses to lipopolysaccharide are changed in the absence of STAT3, leading to enhanced NF-kappa B activation. Our results suggest a model in which STAT3 has critical roles in the development and regulation of innate immunity, and deletion of STAT3 during hematopoiesis results in abnormalities in myeloid cells and causes Crohn's disease-like pathogenesis.

Integrity signals

Registry

Crossref · 10.1073/pnas.0237137100

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Innate immune recognition
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Pathologic Basis of Disease.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,593
STATs and Gene Regulation
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Innate Immunity: The Virtues of a Nonclonal System of Recognition
Medzhitov, R., & Janeway, C. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80412-2 · Cited by 2,434
Stat3: a STAT Family Member Activated by Tyrosine Phosphorylation in Response to Epidermal Growth Factor and Interleukin-6
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
JAKS AND STATS: Biological Implications
Leonard, W. J., & O’Shea, J. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.293 · Cited by 1,826
Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB
Ogura, Y., Inohara, N., Benito, A., Chen, F. F., Yamaoka, S., & Núñez, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008072200 · Cited by 1,357

Show all 44 references

Research works printed but not linked: 2

F S Laroux, K P Pavlick, R E Wolf, M B Grisham News Physiol Sci 16, 272–277 (2001).
10.1128/mcb.13.1.276-288.1993 · DOI

Sorted by citations

STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Yu, H., Kortylewski, M., & Pardoll, D. M. (2006) · Nature reviews. Immunology · doi:10.1038/nri1995 · Cited by 1,841
Inflammatory bowel disease
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D. I., & Sotomayor, E. M. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,747
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,751
Regulation of JAK–STAT signalling in the immune system
Shuai, K., & Liu, B. (2003) · Nature reviews. Immunology · doi:10.1038/nri1226 · Cited by 1,409
STAT3 Mutations in the Hyper-IgE Syndrome
Holland, S. M., DeLeo, F. R., Elloumi, H. Z., Hsu, A. P., Uzel, G., Brodsky, N. N., Freeman, A. F., Demidowich, A. P., Davis, J., Turner, M. L. C., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073687 · Cited by 1,233
Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Self-citation
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
de Jonge, W. J., van der Zanden, E. P., The, F. O., Bijlsma, M. F., van Westerloo, D. J., Bennink, R. J., Berthoud, H.-R., Uematsu, S., Akira, S., van den Wijngaard, R. M., et al. (2005) · Nature Immunology · doi:10.1038/ni1229 · Cited by 1,074
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
Pickert, G., Neufert, C., Leppkes, M., Zheng, Y., Wittkopf, N., Warntjen, M., Lehr, H.-A., Hirth, S., Weigmann, B., Wirtz, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082683 · Cited by 1,043
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Kortylewski, M., Kujawski, M., Wang, T., Sheng, W., Zhang, S., Pilon‐Thomas, S., Niu, G., Kay, H. D., Mulé, J. J., Kerr, W. G., et al. (2005) · Nature Medicine · doi:10.1038/nm1325 · Cited by 1,026
Self-citation
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
Sugimoto, K., Ogawa, A., Mizoguchi, E., Shimomura, Y., Andoh, A., Bhan, A. K., Blumberg, R. S., Xavier, R. J., & Mizoguchi, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33194 · Cited by 1,059
Opportunities and challenges for transcriptome-wide association studies
Wainberg, M., Sinnott-Armstrong, N., Mancuso, N., Barbeira, A., Knowles, D. A., Golan, D., Ermel, R., Ruusalepp, A., Quertermous, T., Hao, K., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0385-z · Cited by 906
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
Serafini, P., Borrello, I., & Bronte, V. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.005 · Cited by 775
STAT3 signaling in immunity
Hillmer, E. J., Zhang, H., Li, H. S., & Watowich, S. S. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.05.001 · Cited by 740
WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27
Pflanz, S., Hibbert, L., Mattson, J. D., Rosales, R., Vaisberg, E., Bazán, J. F., Phillips, J. H., McClanahan, T. K., Malefyt, R. D. W., & Kastelein, R. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2225 · Cited by 698
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose‐John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 689
Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
Lee, H., Herrmann, A., Deng, J.-H., Kujawski, M., Niu, G., Li, Z., Forman, S., Jove, R., Pardoll, D. M., & Yu, H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.015 · Cited by 683
Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease
Brand, S. (2009) · Gut · doi:10.1136/gut.2008.163667 · Cited by 682
The IL-27R (WSX-1) Is Required to Suppress T Cell Hyperactivity during Infection
Villarino, A. V., Hibbert, L., Lieberman, L. A., Wilson, E. H., Mak, T. W., Yoshida, H., Kastelein, R. A., Saris, C. J. M., & Hunter, C. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00300-5 · Cited by 484
Biology and significance of the JAK/STAT signalling pathways
Kiu, H., & Nicholson, S. E. (2012) · Growth Factors · doi:10.3109/08977194.2012.660936 · Cited by 470
Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota
Elson, C. O., Cong, Y., McCracken, V. J., Dimmitt, R. A., Lorenz, R. G., & Weaver, C. T. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00291.x · Cited by 469
The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges
Hutchins, A. P., Díez, D., & Miranda‐Saavedra, D. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/elt028 · Cited by 435
An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells
Cui, W., Liu, Y., Weinstein, J. S., Craft, J., & Kaech, S. M. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.017 · Cited by 410
Self-citation
Granulocyte colony-stimulating factor: Molecular mechanisms of action during steady state and ‘emergency’ hematopoiesis
Panopoulos, A. D., & Watowich, S. S. (2008) · Cytokine · doi:10.1016/j.cyto.2008.03.002 · Cited by 413
Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation
Gao, Q., Wolfgang, M. J., Neschen, S., Morino, K., Horvath, T. L., Shulman, G. I., & Fu, X.-Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0303992101 · Cited by 385
Self-citation
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
Kortylewski, M., Swiderski, P. M., Herrmann, A., Wang, L., Kowolik, C. M., Kujawski, M., Lee, H., Scuto, A., Liu, Y., Yang, C., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1564 · Cited by 384
A Critical Role for Stat3 Signaling in Immune Tolerance
Cheng, F., Wang, H.-W., Cuenca, A., Huang, M., Ghansah, T., Brayer, J., Kerr, W. G., Takeda, K., Akira, S., Schoenberger, S. P., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00232-2 · Cited by 377
Inﬂammatory bowel disease
Teitelbaum, D. H., & Coran, A. G. (2006) · CRC Press eBooks · doi:10.1201/b13237-67 · Cited by 341
The role of STAT3 in leading the crosstalk between human cancers and the immune system
Wang, Y., Shen, Y., Wang, S., Shen, Q., & Zhou, X. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.12.003 · Cited by 343
Sargramostim for Active Crohn's Disease
Korzenik, J. R., Dieckgraefe, B. K., Valentine, J. F., Hausman, D. F., & Gilbert, M. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041109 · Cited by 338
STAT3 is required for Flt3L-dependent dendritic cell differentiation
Laouar, Y., Welte, T., Fu, X.-Y., & Flavell, R. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00332-7 · Cited by 334
Self-citation
Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease
Coskun, M., Salem, M. A., Pedersen, J., & Nielsen, O. H. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.06.007 · Cited by 333
Regulation of Dendritic Cell Differentiation and Antitumor Immune Response in Cancer by Pharmacologic-Selective Inhibition of the Janus-Activated Kinase 2/Signal Transducers and Activators of Transcription 3 Pathway
Nefedova, Y., Nagaraj, S., Rosenbauer, A., Muro‐Cacho, C., Sebti, S. M., & Gabrilovich, D. I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0529 · Cited by 318
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
Bharadwaj, U., Kasembeli, M. M., Robinson, P., & Tweardy, D. J. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018440 · Cited by 314
“…al., 1999; Melillo et al., 2010) and hematopoietic-specific STAT3-KOmice have increased production of inflammatory cytokines (Takeda et al., 1999; Welte et al., 2003; Alonzi et al., 2004; Watowich and Liu, 2010), due to loss of regulation by IL-10 (Kühn et al., 1993; Takeda et al., 1999; Melillo…”
BackgroundInfluential
Interleukin-23/Th17 pathways and inflammatory bowel disease
Abraham, C., & Cho, J. H. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20894 · Cited by 294
Pathways Mediating the Expansion and Immunosuppressive Activity of Myeloid-Derived Suppressor Cells and Their Relevance to Cancer Therapy
Talmadge, J. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0182 · Cited by 286
Targeting STAT3 affects melanoma on multiple fronts
Kortylewski, M., Jove, R., & Yu, H. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-1580-1 · Cited by 286
Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy
Draghiciu, O., Lubbers, J. M., Nijman, H. W., & Daemen, T. (2014) · OncoImmunology · doi:10.4161/21624011.2014.954829 · Cited by 277
IL-6 Trans-Signaling Modulates TLR4-Dependent Inflammatory Responses via STAT3
Greenhill, C. J., Rose-John, S., Lissilaa, R., Ferlin, W., Ernst, M., Hertzog, P. J., Mansell, A., & Jenkins, B. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002971 · Cited by 264
Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases
Skytthe, M. K., Graversen, J. H., & Moestrup, S. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155497 · Cited by 275
Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor
Redell, M. S., Ruiz, M. J., Alonzo, T. A., Gerbing, R. B., & Tweardy, D. J. (2011) · Blood · doi:10.1182/blood-2010-04-280123 · Cited by 258
Review: IL-6 Transsignaling: The In Vivo Consequences
Jones, S. A., Richards, P. J., Scheller, J., & Rose‐John, S. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.241 · Cited by 254
The IL-27 Receptor (WSX-1) Is an Inhibitor of Innate and Adaptive Elements of Type 2 Immunity
Artis, D., Villarino, A. V., Silverman, M. A., He, W., Thornton, E. M., Mu, S., Summer, S., Covey, T. M., Huang, E., Yoshida, H., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5626 · Cited by 239
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations
Will, B., Zhou, L., Vogler, T. O., Ben-Neriah, S., Schinke, C., Tamari, R., Yu, Y., Bhagat, T. D., Bhattacharyya, S., Barreyro, L., et al. (2012) · Blood · doi:10.1182/blood-2011-12-399683 · Cited by 240
Interleukin‐10 suppression of myeloid cell activation — a continuing puzzle
Williams, L. M., Ricchetti, G., Sarma, U., Smallie, T., & Foxwell, B. M. J. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01988.x · Cited by 237
Activation Pattern of Signal Transducers and Activators of Transcription (STAT) Factors in Inflammatory Bowel Diseases
Mudter, J., Weigmann, B., Bartsch, B., Kießlich, R., Strand, D. J., Galle, P. R., Lehr, H. A., Schmidt, J., & Neurath, M. F. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40615.x · Cited by 232
Transcription Factor STAT3 and Type I Interferons Are Corepressive Insulators for Differentiation of Follicular Helper and T Helper 1 Cells
Ray, J. P., Marshall, H. D., Laidlaw, B. J., Staron, M. M., Kaech, S. M., & Craft, J. E. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.005 · Cited by 242
Self-citation
Intestinal macrophages: unique effector cells of the innate immune system
Smith, P. D., Ochsenbauer‐Jambor, C., & Smythies, L. E. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00288.x · Cited by 225
Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function
Melillo, J. A., Song, L., Bhagat, G., Blazquez, A. B., Plumlee, C. R., Lee, C., Berin, C., Reizis, B., & Schindler, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902960 · Cited by 225
The Hyper-IgE Syndromes
Freeman, A. F., & Holland, S. M. (2008) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2008.01.005 · Cited by 228
STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation
Sheng, W., Yang, F., Zhou, Y., Yang, H., Low, P. Y., Kemeny, D. M., Tan, P., Moh, A., Kaplan, M. H., Zhang, Y., et al. (2014) · Cell Research · doi:10.1038/cr.2014.154 · Cited by 203
Self-citation
Epstein-Barr Virus Infection Alters Cellular Signal Cascades in Human Nasopharyngeal Epithelial Cells
Lo, A. K. F., Lo, K. W., Tsao, S. W., Wong, H., Hui, J. W., To, K. F., Hayward, S. D., Chui, Y., Lau, Y., Takada, K., et al. (2006) · Neoplasia · doi:10.1593/neo.05625 · Cited by 201
STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils
Panopoulos, A. D., Zhang, L., Snow, J. W., Jones, D. M., Smith, A. M., El Kasmi, K. C., Liu, F., Goldsmith, M. A., Link, D. C., Murray, P. J., et al. (2006) · Blood · doi:10.1182/blood-2006-02-003012 · Cited by 198
Activation of Dendritic Cells via Inhibition of Jak2/STAT3 Signaling
Nefedova, Y., Cheng, P., Gilkes, D. M., Blaskovich, M. A., Beg, A. A., Sebti, S. M., & Gabrilovich, D. I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4338 · Cited by 197
Role of Stat3 in suppressing anti-tumor immunity
Kortylewski, M., & Yu, H. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.010 · Cited by 204
Cutting Edge: A Transcriptional Repressor and Corepressor Induced by the STAT3-Regulated Anti-Inflammatory Signaling Pathway
El Kasmi, K. C., Smith, A. M., Williams, L., Neale, G., Panopolous, A., Watowich, S. S., Häcker, H., Foxwell, B. M. J., & Murray, P. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7215 · Cited by 182
Cell Type–Dependent Pro- and Anti-Inflammatory Role of Signal Transducer and Activator of Transcription 3 in Alcoholic Liver Injury
Horiguchi, N., Wang, L., Mukhopadhyay, P., Park, O., Jeong, W. I., Lafdil, F., Osei‐Hyiaman, D., Moh, A., Fu, X. Y., Pacher, P., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.016 · Cited by 180
Self-citation
Novel pathophysiological concepts of inflammatory bowel disease
Hibi∥, T., & Ogata, H. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-005-1744-3 · Cited by 176
A genetic and developmental pathway from STAT3 to the OCT4–NANOG circuit is essential for maintenance of ICM lineages in vivoPreprint
Do, D. V., Ueda, J., Messerschmidt, D. M., Lorthongpanich, C., Zhou, Y., Feng, B., Guo, G., Lin, P. J., Hossain, M. Z., Zhang, W., et al. (2013) · Genes & Development · doi:10.1101/gad.221176.113 · Cited by 184
Self-citation
Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance
de Almeida, P. E., Meyer, E. H., Kooreman, N. G., Diecke, S., Dey, D., Sánchez-Freire, V., Hu, S., Ebert, A., Odegaard, J. I., Mordwinkin, N. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4903 · Cited by 174
IL-23 and Autoimmunity: New Insights into the Pathogenesis of Inflammatory Bowel Disease
Abraham, C., & Cho, J. H. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.60.051407.123757 · Cited by 169
Activation of the STAT pathway in acute lung injury
Severgnini, M., Takahashi, S., Rozo, L., Homer, R., Kuhn, C., Jhung, J. W., Perides, G., Steer, M. L., Hassoun, P. M., Fanburg, B. L., et al. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00349.2003 · Cited by 164
Endothelial Cells Require STAT3 for Protection against Endotoxin-induced Inf lammation
Kano, A., Wolfgang, M. J., Gao, Q., Jacoby, J. J., Chai, G.-X., Hansen, W. R., Iwamoto, Y., Pober, J. S., Flavell, R. A., & Fu, X.-Y. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030077 · Cited by 163
Self-citation
Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer
Bharadwaj, U., Eckols, T. K., Kolosov, M. I., Kasembeli, M. M., Adam, A., Torres, D., Zhang, X., Dobrolecki, L. E., Wei, W., Lewis, M. T., et al. (2014) · Oncogene · doi:10.1038/onc.2014.72 · Cited by 161
Expression of IL-24, an Activator of the JAK1/STAT3/SOCS3 Cascade, Is Enhanced in Inflammatory Bowel Disease
Andoh, A., Shioya, M., Nishida, A., Bamba, S., Tsujikawa, T., Kim‐Mitsuyama, S., & Fujiyama, Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804169 · Cited by 156
Induced Reactivity of Intestinal CD4+ T Cells with an Epithelial Cell Lectin, Galectin-4, Contributes to Exacerbation of Intestinal Inflammation
Hokama, A., Mizoguchi, E., Sugimoto, K., Shimomura, Y., Tanaka, Y., Yoshida, M., Rietdijk, S. T., de Jong, Y. P., Snapper, S. B., Terhorst, C., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.05.009 · Cited by 155
Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor
Chuang, K., Altuwaijri, S., Li, G., Lai, J., Chu, C., Lai, K., Lin, H., Hsu, J., Keng, P., Wu, M., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082521 · Cited by 160
Signaling by STATs.
Ivashkiv, L. B., & Hu, X. (2004) · Arthritis Research · doi:10.1186/ar1197 · Cited by 160
STAT3 controls the neutrophil migratory response to CXCR2 ligands by direct activation of G-CSF-induced CXCR2 expression and via modulation of CXCR2 signal transduction
Nguyen-Jackson, H., Panopoulos, A. D., Zhang, H., Li, H. S., & Watowich, S. S. (2010) · Blood · doi:10.1182/blood-2009-08-240317 · Cited by 151
Role of STAT3 in CD4+CD25+FOXP3+ Regulatory Lymphocyte Generation: Implications in Graft-versus-Host Disease and Antitumor Immunity
Pallandre, J., Brillard, E., Créhange, G., Radlovic, A., Rémy-Martin, J.-P., Saas, P., Rohrlich, P., Pivot, X. B., Ling, X., Tiberghien, P., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7593 · Cited by 159
The vagus nerve as a modulator of intestinal inflammation
van der Zanden, E. P., Boeckxstaens, G. E., & de Jonge, W. J. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01252.x · Cited by 155
Mechanisms regulating dendritic cell specification and development
Watowich, S. S., & Liu, Y. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00949.x · Cited by 157
Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells
Fornek, J. L., Tygrett, L. T., Waldschmidt, T. J., Poli, V., Rickert, R. C., & Kansas, G. S. (2006) · Blood · doi:10.1182/blood-2005-07-2871 · Cited by 148
Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis
Grabner, B., Schramek, D., Mueller, K. M., Moll, H. P., Svinka, J., Hoffmann, T., Bauer, E., Blaas, L., Hruschka, N., Zboray, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms7285 · Cited by 146
Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
Beebe, J., Liu, J., & Zhang, J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.006 · Cited by 144
STAT3 regulates NF-κB recruitment to the IL-12p40 promoter in dendritic cells
Hoentjen, F., Sartor, R. B., Ozaki, M., & Jobin, C. (2004) · Blood · doi:10.1182/blood-2004-04-1309 · Cited by 143
G-CSF-mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus-induced suppression of TNF production in macrophages
Kim, S. O., Sheikh, H. I., Ha, S.-D., Martins, A. J., & Reid, G. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00763.x · Cited by 141
Mouse hematopoietic cell–targeted STAT3 deletion: stem/progenitor cell defects, mitochondrial dysfunction, ROS overproduction, and a rapid aging–like phenotype
Mantel, C., Messina‐Graham, S., Moh, A., Cooper, S. H., Hangoc, G., Fu, X.-Y., & Broxmeyer, H. E. (2012) · Blood · doi:10.1182/blood-2012-01-404004 · Cited by 139
Self-citation
Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans
Bonifazi, P., Zelante, T., D'Angelo, C., LUCA, A. D., Moretti, S., Bozza, S., Perruccio, K., Iannitti, R. G., Giovannini, G., Volpi, C., et al. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.17 · Cited by 142
STAT3: A Target to Enhance Antitumor Immune Response
Lee, H., Pal, S. K., Reckamp, K. L., Figlin, R. A., & Yu, H. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_51 · Cited by 138
GRIM-19 Interacts with Nucleotide Oligomerization Domain 2 and Serves as Downstream Effector of Anti-bacterial Function in Intestinal Epithelial Cells
Barnich, N., Hisamatsu, T., Aguirre, J. E., Xavier, R. J., Reinecker, H., & Podolsky, D. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413776200 · Cited by 134
Role of STAT3 in inflammatory bowel disease
Sugimoto, K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5110 · Cited by 133
The Myeloid Differentiation Factor 88 (MyD88) Is Required for CD4+ T Cell Effector Function in a Murine Model of Inflammatory Bowel Disease
Fukata, M., Breglio, K. J., Chen, A., Vamadevan, A. S., Goo, T., Hsu, D. S., Conduah, D. E., Xu, R., & Abreu, M. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1886 · Cited by 130
Aberrant Inflammation and Lethality to Septic Peritonitis in Mice Lacking STAT3 in Macrophages and Neutrophils
Matsukawa, A., Takeda, K., Shinji, K. U. D. O., Maeda, T., Kagayama, M., & Akira, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6198 · Cited by 131
GM-CSF Promotes Macrophage Alternative Activation after Renal Ischemia/Reperfusion Injury
Huen, S. C., Huynh, L. K., Marlier, A., Lee, Y., Moeckel, G. W., & Cantley, L. G. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014060612 · Cited by 130
STAT3 Activation Regulates Growth, Inflammation, and Vascularization in a Mouse Model of Gastric Tumorigenesis
Judd, L. M., Bredin, K., Kalantzis, A., Jenkins, B. J., Ernst, M., & Giraud, A. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.018 · Cited by 131
Microarray Analyses of Peripheral Blood Cells Identifies Unique Gene Expression Signature in Psoriatic Arthritis
Batliwalla, F., Li, W., Ritchlin, C. T., Xiao, X., Brenner, M., Laragione, T., Shao, T., Durham, R. A., Kemshetti, S., Schwarz, E. M., et al. (2005) · Molecular Medicine · doi:10.2119/2006-00003.gulko · Cited by 125
Pathogenesis of myeloproliferative neoplasms
Skoda, R. C., Duek, A., & Grisouard, J. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.06.007 · Cited by 135
Host-microbiota interactions in inflammatory bowel disease
Elson, C. O., & Cong, Y. (2012) · Gut Microbes · doi:10.4161/gmic.20228 · Cited by 125
Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications
Mudter, J., & Neurath, M. F. (2006) · Gut · doi:10.1136/gut.2005.090464 · Cited by 126
New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation
Wei, L., Laurence, A. D. J., & O’Shea, J. J. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.07.011 · Cited by 126
Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy
Kortylewski, M., Kujawski, M., Herrmann, A., Yang, C., Wang, L., Liu, Y., Salcedo, R., & Yu, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3031 · Cited by 122
Control of intestinal homeostasis by regulatory T cells and dendritic cells
Coombes, J. L., & Maloy, K. J. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.01.001 · Cited by 127
The Transcriptional Repressor Gfi1 Controls STAT3-Dependent Dendritic Cell Development and Function
Rathinam, C., Geffers, R., Yücel, R., Buer, J., Welte, K., Möröy, T., & Klein, C. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.007 · Cited by 127
From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies
Fantini, M. C., & Guadagni, I. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.01.012 · Cited by 117
Unphosphorylated STAT3 modulates alpha7 nicotinic receptor signaling and cytokine production in sepsis
Peña, G., Cai, B., Liu, J., van der Zanden, E. P., Deitch, E. A., de Jonge, W. J., & Ulloa, L. (2010) · European Journal of Immunology · doi:10.1002/eji.201040540 · Cited by 116
Signal Transducers and Activators of Transcription 3 Signaling Pathway
Musso, A., Dentelli, P., Carlino, A., Chiusa, L., Repici, A., Sturm, A., Fiocchi, C., Rizzetto, M., Pegoraro, L., Sategna-Guidetti, C., et al. (2005) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200502000-00001 · Cited by 116

Authors: Welte, T., Zhang, S. S. M., Wang, T., Zhang, Z., Hesslein, D. G. T., Yin, Z., Kano, A., Iwamoto, Y., Li, E., Craft, J. E., Bothwell, A. L. M., Fikrig, E., Koni, P. A., Flavell, R. A., & Fu, X.-Y.
Affiliations: Howard Hughes Medical Institute (US)
ORCID: Welte, Thomas
Wang, Tian
Zhang, Zhiyuan
Yin, Zhinan
Li, En
Craft, Joseph E.
Bothwell, Alfred L. M.
Fikrig, Erol
Koni, Pandelakis A.
Flavell, Richard A.
Fu, Xin-Yuan
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2003-02-05
Volume: 100
Issue: 4
Pages: 1879-1884
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0237137100
PMC: PMC149927
OpenAlex: W2148996267
Cited by: 381
References: 44
Citations by year: 2026: 1 · 2025: 8 · 2024: 3 · 2023: 6 · 2022: 4 · 2021: 12 · 2020: 14 · 2019: 16 · 2018: 8 · 2017: 14 · 2016: 19 · 2015: 15 · 2014: 25 · 2013: 24 · 2012: 19
FWCI: 12.86
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Howard Hughes Medical Institute
Österreichischen Akademie der Wissenschaften
National Institutes of Health (5r01ar044906-05)
National Institute of Allergy and Infectious Diseases (AI-34522, R01AI034522)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR44906)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords: STAT3, Crohn's disease, hematopoiesis, bone marrow, innate immunity, myeloid cell proliferation, intestinal inflammation, NF-κB activation, lipopolysaccharide signaling, TNF-α, interferon-gamma, granuloma formation, tissue-specific gene deletion
MeSH terms: Animals, Bone Marrow Cells, Cells, Cultured, Crohn Disease, DNA-Binding Proteins, Hematopoiesis, Immunity, Trans-Activators, Gene Deletion, STAT3 Transcription Factor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

STAT3 deletion during hematopoiesis causes Crohn’s disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks